SXC Health Solutions to buy Catalyst in $4.4-billion deal

Written by Bloomberg | Updated: Apr 19 2012, 07:37am hrs
SXC Health Solutions has agreed to buy Catalyst Health Solutions in a transaction valued at $4.4 billion.

Catalyst shareholders will receive $28 in cash and 0.6606 shares of SXC stock for each Catalyst share, which implies a purchase price of $81.02 per Catalyst share and a premium of 28% based on the closing stock prices of SXC and Catalyst on April 17, the companies said today in a statement.